NewLink Genetics Corporation Reports Third Quarter 2012 Financial Results

[at noodls] – AMES, IA — (Marketwire) — 10/31/12 — NewLink Genetics Corporation (NASDAQ: NLNK), a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today reported … more

View todays social media effects on NLNK

View the latest stocks trending across Twitter. Click to view dashboard